JANX (Janux Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on JANX (Janux Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

JANX

Janux Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Tops Revenue Estimates
Nov 6, 2025
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
Nov 6, 2025
Janux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last?
Oct 29, 2025
Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial
Oct 21, 2025
Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?
Oct 10, 2025
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
Sep 15, 2025
Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration
Aug 18, 2025
Janux Therapeutics First Half 2025 Earnings: US$0.93 loss per share (vs US$0.41 loss in 1H 2024)
Aug 10, 2025
Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
Aug 7, 2025
Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck
Aug 5, 2025
Janux Therapeutics Highlights Pipeline Progress and Best-in-Class Potential of Novel Bispecific Platform for Autoimmune Diseases at Virtual R&D Day
Jul 24, 2025
JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
Jun 24, 2025

Reviews